- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01925508
Evaluation of a Physical Therapy Protocol on Quality of Life Musculoskeletal Pain and Anxiety in Women With Preeclampsia
May 10, 2016 updated by: Michelle de Souza Rangel Machado, University of Sao Paulo
Evaluation of a Physical Therapy Protocol on Quality of Life, Musculoskeletal Pain and Anxiety in Women With Preeclampsia
The purpose of this study is to verify that the implementation of a protocol physiotherapy musculoskeletal pain and reduces anxiety and improves quality of life in patients hospitalized at the clinic of high-risk pregnancies at the Hospital das Clinicas of Ribeirao Preto, with a diagnosis of preeclampsia and chronic hypertension with superimposed preeclampsia.
Where patients will be recruited, answered questionnaires before and after application of physiotherapy protocol.
Study Overview
Status
Completed
Detailed Description
The hypertensive disorders in pregnancy affect approximately 5-8% of pregnant women worldwide, contributing significantly to serious maternal and fetal complications.
There are various forms of hypertensive disorders that occur during pregnancy and among them are pre-eclampsia and chronic hypertension with superimposed preeclampsia.
These two disorders present with high blood pressure and proteinuria, which leads often to hospitalization of these women.
It is believed that with such an accent hospitalization occur in pain conditions that often affect pregnant women.
Given these complications, this study aims to evaluate the effectiveness of a physical therapy protocol used in pregnant women with preeclampsia admitted with respect to blood pressure levels, responses maternal-fetal and perinatal, and measure an expected improvement in quality of life in the reduction of reported pain and anxiety.
The study will include the participation of women with preeclampsia and chronic hypertension with superimposed pre-eclampsia, hospitalized, with no significant complications that may hinder the normal progress of pregnancy.
Pregnant women will answer questionnaires about quality of life, anxiety and scales to identify musculoskeletal discomfort.
Monitoring will be done both the pregnant woman and the fetus through imaging and laboratory, in addition, pregnant women carry the exercise protocol previously proposed work.
This is expected to achieve satisfactory results in the improvement of maternal and fetal hemodynamics in aspects of muscle discomfort and quality of life in a secure way for these women.
Study Type
Observational
Enrollment (Actual)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
São Paulo
-
Ribeirao Preto, São Paulo, Brazil, 14040030
- Hospital das Clinicas of Ribeirao Preto
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
The population will be recruited in the infirmary of the high-risk pregnancy Hostptal das Clinicas of Ribeirao Preto
Description
Inclusion Criteria:
- Pregnant women with gestational age between 24 and 38 weeks
- Hospitalized in the sector of high-risk pregnancy clinic of the Hospital of Ribeirão Preto with diagnosis of preeclampsia and chronic hypertension with superimposed pre-eclampsia
- With the absence of other maternal diseases and absence of fetal diseases by diagnostic ultrasound examinations and fetal
Exclusion Criteria:
- Pregnant women who became symptomatic (blurred vision, epigastric pain, headache) secondary to the hypertensive process;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Quality of life, anxiety and pain in pre-eclampsia
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Michelle R Machado, graduation, University of Sao Paulo
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2012
Primary Completion (Actual)
August 1, 2013
Study Completion (Actual)
October 1, 2013
Study Registration Dates
First Submitted
July 31, 2013
First Submitted That Met QC Criteria
August 15, 2013
First Posted (Estimate)
August 19, 2013
Study Record Updates
Last Update Posted (Estimate)
May 12, 2016
Last Update Submitted That Met QC Criteria
May 10, 2016
Last Verified
May 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GO-021083
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pre-eclampsia or Eclampsia With Pre-existing Hypertension
-
Amsterdam UMCZonMw: The Netherlands Organisation for Health Research and DevelopmentNot yet recruitingPre-Eclampsia | HELLP Syndrome | Pre-eclampsia or Eclampsia With Pre-existing Hypertension | HELLP | Pre-Eclampsia; Complicating Pregnancy | Pre-Eclampsia Onset Less Than 37 Weeks | Pre-Eclampsia as Antepartum Condition | Pre-Eclampsia; Affecting Fetus | HELLP Syndrome Complicating Pregnancy
-
Dow University of Health SciencesCompletedPre-eclampsia | Hypertension, Pregnancy Induced | Hydralazine Adverse Reaction | Pre-eclampsia Superimposed Pre-existing HypertensionPakistan
-
University of Mississippi Medical CenterCompletedPregnancy; Proteinuria, With Hypertension (Severe Pre-eclampsia) | Delivery; Proteinuria, With Gestational Hypertension (Pre-eclampsia, Severe) | Pregnancy; Hypertension, Gestational Hypertension, With Albuminuria (Severe Pre-eclampsia)United States
-
Bandırma Onyedi Eylül UniversityCompletedPre-Eclampsia | Gestational Hypertension | Chronic Hypertension With Pre-Eclampsia | Superimposed Pre-EclampsiaTurkey
-
University of WashingtonUniversity of Cape TownCompletedSevere Pre-eclampsia | Mild Pre-eclampsiaSouth Africa, United States
-
Complejo Hospitalario Dr. Arnulfo Arias MadridCompletedSevere Pre-eclampsia With Postnatal ComplicationPanama
-
Copenhagen University Hospital, HvidovreFerring Pharmaceuticals; Gedeon Richter Ltd.RecruitingPreterm Labor | Gestational Diabetes | Pre-eclampsia | Neonatal Morbidity | Pre-eclampsia or Eclampsia With Pre-existing Hypertension | Placental Abruption | ART | Neonatal Mortality | Pre-Eclampsia, Severe | Intrauterine Growth Restriction (IUGR) | Pre-Eclampsia; Mild | Oocyte Donation | Pre-Eclampsia; Complicating... and other conditionsDenmark
-
Evergreen Therapeutics, Inc.Not yet recruiting
-
WithingsRecruitingHypertension | Pre-eclampsiaArmenia
-
William Marsh Rice UniversityUniversity of MalawiCompleted